§ Federal grant opportunity · RFA-MH-27-125
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
National Institutes of Health is accepting applications for Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed). The deadline is October 28, 2027 and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- October 28, 2027
- Award range
- Award amount not published
- Eligibility
- for profit organizations other than small businesses, private institutions of higher education, small businesses, nonprofits non higher education without 501c3, city or township governments, other, county governments, state governments, federally recognized native american tribal governments, special district governments, other native american tribal organizations, nonprofits non higher education with 501c3, public and state institutions of higher education, independent school districts, public and indian housing authorities
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- RFA-MH-27-125
Program overview
The purpose of this notice of funding opportunity (NOFO) is to identify modifiable mechanisms and therapeutic targets to address central nervous system (CNS) complications associated with human immunodeficiency virus (HIV). The initiative supports a phased research approach beginning with the identification of patient phenotypes characterized by convergent pathophysiological features, followed by the discovery and experimental validation of molecular mechanisms using innovative in-vitro and in-vivo models. The goal of this NOFO is to advance therapeutic target, and intervention discovery to address the multifactorial and heterogeneous nature of HIV-associated CNS dysfunction.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before October 28, 2027, allowing time for registration and validation.
Related grant opportunities
- RESTORE Act Direct Component - Non-Construction Activities
- RESTORE Act Centers of Excellence Research Grants Program
- National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
- Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.